Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! GSK strengthens vaccines business with acquisition of Okairos Wednesday 29 May 2013, London UK -- GlaxoSmithKline today announced that it has acquired Okairos AG , a specialist developer of vaccine platform technologies for a 250 million in cash.
http://www.biospace.com/news_story.aspx?StoryID=298146&full=1
http://www.biospace.com/news_story.aspx?StoryID=298146&full=1
No comments:
Post a Comment